Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding the Transition from Normal Melanocytes to Nevus to Melanoma (NevustoMel)

NCT06605417 is registered in ClinicalTrials.gov with Fundacion Clinic per a la Recerca Biomédica as lead sponsor.

NCT NCT06605417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06605417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma (NevustoMel)
Lead sponsor
Fundacion Clinic per a la Recerca Biomédica
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
November 30, 2026
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congenital melanocytic nevi, melanoma, skin, nevi and melanomas